Biotech

US Patent And Trademark Office Board of Appeals Reverses All Benitec Limited (ASX:BLT) '099 Graham Patent Rejections

🕔9/30/2010 10:19:32 AM

Benitec Limited (ASX:BLT) (PINK:BNIKF) are delighted to announce that the United States Patent and Trademark Office's (USPTO) Board of Patent Appeals and Interferences has issued a decision reversing all previous rejections in the US 6,573,099 (the '099 Graham patent) appeal.

Read Full Article

Benitec Limited (ASX:BLT) Granted Further Hepatitis C RNAi Patent In US

🕔9/29/2010 11:02:23 AM

Benitec Limited (ASX:BLT) (PINK:BNIKF), a leading Australian based company specialising in RNA interference (RNAi) technology, is pleased to announce that the US patent application for "RNAi Expression Constructs" has been successfully granted by the United States Patent and Trademark Office (USPTO) as US Patent No. 7,803,611.

Read Full Article

Acquisition Of US Company Ratified By Mesoblast Limited (ASX:MSB) Shareholders

🕔9/22/2010 6:07:17 PM

Shareholders of Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today overwhelmingly approved the acquisition of its United States associate company, Angioblast Systems Inc.

Read Full Article

Speech By Mesoblast Limited (ASX:MSB) Chairman Brian Jamieson To Extraordinary General Meeting

🕔9/22/2010 2:38:24 PM

Mesoblast Limited (ASX:MSB) (PINK:MBLTY) is pleased to release its Chairman Brian Jamieson's speech at the Extraordinary General Meeting.

Read Full Article

Mesoblast Limited (ASX:MSB) Featured Prominently At International Scientific Conferences

🕔9/20/2010 9:28:25 AM

Clinical advances by regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) were featured prominently at the 39th annual meeting of the International Society for Experimental Hematology (ISEH) and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Asia Pacific meeting, both held over the past several days.

Read Full Article

Benitec Limited (ASX:BLT) To Broaden Research And Development Pipeline

🕔9/3/2010 5:40:59 PM

Benitec Limited (ASX:BLT) (PINK:BNIKF), a leading Australian based company specialising in RNA interference (RNAi) technology, is pleased to announce a strategy update and broadening of its R&D pipeline following the recent Board and management changes announced earlier this year.

Read Full Article

Benitec Limited (ASX:BLT) Announce Another Patent in Graham Family Allowed in The US

🕔9/2/2010 11:05:34 AM

The Directors of Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to provide this update on the progress of the patent family "Control of Gene Expression". The "Control of Gene Expression" patents are part of the foundational Graham RNAi patent family. CSIRO and Benitec have received a Notice of Allowance issued by the United States Patent and Trademark Office (USPTO) on 2 September 2010, allowing US patent application 10/759,841 "Synthetic Genes and Genetic Constructs comprising the same".

Read Full Article